Rocchi, Angela; Miller, Elizabeth; Hopkins, Robert B.; … - In: PharmacoEconomics 30 (2012) 3, pp. 229-246
clinical efficacy and cost effectiveness of new drugs, and then to make formulary listing recommendations to Canadian publicly … (OR 9), request for reconsideration (OR 10) and price as the only economic evidence used (OR 18). Incremental cost …